Behera Sambit Kumar, Behera Prajyoti, Behera Jyoti Ranjan, Behera Gayatri
Gastroenterology, Srirama Chandra Bhanja (SCB) Medical College, Cuttack, IND.
Physiology, Institute of Medical Sciences (IMS) & SUM Hospital, Bhubaneswar, IND.
Cureus. 2023 Dec 28;15(12):e51259. doi: 10.7759/cureus.51259. eCollection 2023 Dec.
Cardiac functional abnormalities are common in patients with cirrhosis of the liver. Nonetheless, the effect of portal hypertension and liver disorder on cardiac abnormalities is yet to be investigated. The current study evaluated the contribution of cirrhotic and non-cirrhotic portal hypertension as the potential cause of cardiac abnormalities.
The present study was a cross-sectional observational study. After excluding known heart diseases, 128 patients with portal hypertension from different causes were enrolled in the study. Cardiac functional activity was assessed by electrocardiogram (ECG) and transthoracic echocardiography (TTE). Results: This study included a total of 128 patients, out of which 24 had extrahepatic portal vein obstruction (EHPVO), four patients had Budd-Chiari syndrome and 100 had liver cirrhosis. Normal ventricular function was observed in patients with EHPVO and Budd-Chiari syndrome. Sixty-eight percent of cases had liver cirrhosis diastolic abnormalities. The mean QTc interval in patients with cirrhotic cardiomyopathy (CCM) was 0.49 ± 0.05 sec which was significantly increased when compared to patients without CCM with 0.432 ± 0.07 at =0.0016. The Child Turcotte Pugh (CTP) score and MELD (Model for End-Stage Liver Disease) score in patients with CCM were significantly higher as compared to patients without CCM. All alcoholic cirrhotic and non-alcoholic cirrhotic patients had equal prevalence of diastolic dysfunction (-value >0.05).
Patients with Child class C or a high MELD score are associated with a higher prevalence rate of CCM while normal cardiac function was observed among patients having portal hypertension due to extrahepatic causes. We recommend cardiac evaluation by echocardiography in all cirrhotic patients. Institution of specific medical therapy and early referral for liver transplantation should be considered to improve survival in patients with decompensated cirrhosis.
心脏功能异常在肝硬化患者中很常见。然而,门静脉高压和肝脏疾病对心脏异常的影响尚待研究。本研究评估了肝硬化性和非肝硬化性门静脉高压作为心脏异常潜在原因的作用。
本研究为横断面观察性研究。排除已知心脏病后,纳入128例不同病因的门静脉高压患者。通过心电图(ECG)和经胸超声心动图(TTE)评估心脏功能活动。结果:本研究共纳入128例患者,其中24例有肝外门静脉阻塞(EHPVO),4例有布加综合征,100例有肝硬化。EHPVO和布加综合征患者心室功能正常。68%的肝硬化病例有舒张功能异常。肝硬化性心肌病(CCM)患者的平均QTc间期为0.49±0.05秒,与无CCM的患者相比显著增加,无CCM患者为0.432±0.07秒,P=0.0016。CCM患者的Child-Turcotte Pugh(CTP)评分和终末期肝病模型(MELD)评分显著高于无CCM的患者。所有酒精性肝硬化和非酒精性肝硬化患者舒张功能障碍的患病率相同(P值>0.05)。
Child C级或MELD评分高的患者CCM患病率较高,而肝外原因导致门静脉高压的患者心脏功能正常。我们建议对所有肝硬化患者进行超声心动图心脏评估。应考虑采用特定的药物治疗并尽早转诊进行肝移植,以提高失代偿期肝硬化患者的生存率。